Board of Directors

Executive Committee

Kathryn G. Schubert, MPP
SWHR President and CEO
Kathryn G. Schubert, MPP
SWHR President and CEO

Schubert previously worked for the Society for Maternal-Fetal Medicine (SMFM), where she served as the organization’s chief advocacy officer, growing SMFM’s role nationally and building its reputation in women’s health.

As a member of SMFM’s executive team, Schubert played a critical role in the development of SMFM’s budget and strategic plan. She also acted as a trusted leader and consensus builder among women’s health stakeholders, particularly in the policy arena.

Prior to SMFM, Schubert served as senior vice president at CRD Associates, where she advised clients — including nonprofit patient advocacy groups, medical professional organizations, and private companies — on government relations and public policy related to health and biomedical research issues, among others. Schubert has also spent time working in legislative roles on Capitol Hill. She received her BA from Mary Washington College and her Masters of Public Policy from George Washington University.

Shontelle Dodson, PharmD

Shontelle Dodson, PharmD, is the Senior Vice President of Health Systems at Astellas and has extensive clinical and research experience in the health care and pharmaceutical industries. She previously served as Senior Vice President and Head of Medical Affairs Americas at Astellas.

After several years of service in direct patient care at the Department of Veterans Affairs, Dodson spent 11 years at Pfizer Inc. in various leadership roles, including the U.S. Viagra Medical Team Leader and Senior Director, Group Leader supporting the urology and respiratory franchise. Following her work with Pfizer, Dodson served as Vice President of Medical Affairs at GTx Inc. In this capacity, she led the Phase 3 clinical development of a selective androgen receptor modulator for the prevention and treatment of muscle wasting in patients with cancer, including key economic and health outcomes assessments to support product utilization and valuation. Under her leadership at Astellas, the health outcomes group has pioneered multiple, innovative real world data projects, including two national registries in prostate cancer and overactive bladder, as well as partnered research with leading managed care and academic organizations.

She has received multiple awards for leadership and innovation during her career, including the National Healthcare Business Women’s Association Rising Star.

Dodson holds a Doctor of Pharmacy degree from Mercer University School of Pharmacy and completed a postdoctoral residency at the Department of Veterans Affairs Medical Center in Nashville, Tenn.

Gretta Stone
Gretta Stone

Gretta Stone is a health policy communications consultant at Reservoir Communications Group with deep knowledge of the biopharmaceutical sector and the health system more broadly.

At Reservoir, she works with a range of clients on advocacy, reputation, and organization brand. Before coming to Reservoir, she served as Deputy Vice President of Policy & Research at the Pharmaceutical Research and Manufacturers of America (PhRMA), where she led a range of issues related to the value of medicines, the R&D process, FDA regulation, and personalized medicine. In her more than 15 years at PhRMA, she worked extensively on orphan drugs, cancer, the biopharmaceutical pipeline, the research ecosystem, the cost of medicines, and marketing and promotion. Prior to joining PhRMA, Stone worked in a lab researching language and the brain at Georgetown University, where she received a Bachelor of Science in biology.

Roberta Gartside, MD, FACS
Immediate Past Chair
Roberta Gartside, MD, FACS
Immediate Past Chair

Roberta L. Gartside, MD, is a leading plastic surgeon in the Washington, D.C., area. She dedicates her practice to improving the appearance of her patients through the use of the most advanced aesthetic techniques and technology, including face life, liposuction, and breast augmentation.

Gartside is passionate about her work as a plastic surgeon treating women who have been diagnosed with breast cancer and may need to undergo either a mastectomy or breast conserving therapy with oncoplastic reconstruction. Breast reconstruction following a mastectomy or lumpectomy can be an important part of the recovery process for women diagnosed with breast cancer. Gartside helps her patients through what could be an emotionally stressful and physically taxing time.

Gartside is committed to expert reconstructive care and believes that providing support and compassion is one of her main duties as a plastic surgeon.

Gartside holds a bachelor of science degree from Elizabethtown College in Pennsylvania and an MD from Temple University School of Medicine, and she has completed residencies in general surgery and plastic surgery at the Medical Center Hospital of Vermont and the George Washington University Medical Center. She is the author of several influential articles, including The Biology of Human Malignant Melanoma.

She is a fellow in the American College of Surgeons as well as a member of the American Society of Plastic Surgeons and past Vice President for Membership and Communications. She was the ASPS representative to the National Accreditation Program for Breast Center. Locally, Gartside is a member of the National Capital Society of Plastic Surgeons. She also serves as a trustee for Elizabethtown College.

Click here to visit her website.

Dawn Halkuff

Dawn Halkuff is the Chief Commercial Officer at TherapeuticsMD, a health care company focused on developing products exclusively for women.

Halkuff has held numerous senior-level commercial and marketing positions over 20 years. Most recently, she was Senior Vice President of the Pfizer Consumer Healthcare Wellness Organization and a member of the Consumer Global Leadership Team. Halkuff was also commercial lead for sales and marketing of the Pfizer Women’s Health Division, focusing on the company’s reinvestment in hormone therapy treatment. From 2005 to 2010, she was Head of Global Innovation at Weight Watchers International, where she created new weight-loss products, services, and solutions for women worldwide.

She holds a BA in Psychology from University of Connecticut and an MBA from Pennsylvania State University.

Jenelle Krishnamoorthy, PhD

Jenelle S. Krishnamoorthy, PhD, is the associate vice president for global policy, communications and population health at Merck.

Prior to joining Merck in January 2015, Krishnamoorthy worked on health policy for 10 years for Sen. Tom Harkin (D-Iowa). She served for five years as the health policy director for the Senate’s Health, Education, Labor and Pensions Committee when Harkin was chairman. Krishnamoorthy first joined Harkin’s team as an American Association for the Advancement of Science (AAAS) Fellow in 2003 and 2004. During 2004 and 200, she worked at the U.S. State Department in the Bureau of South Asian Affairs on health, science, technology, and environment issues with India on a AAAS Diplomacy Fellowship.

Trained as a licensed clinical psychologist, Krishnamoorthy completed her pediatric clinical psychology internship and postdoctoral fellowship at Brown Medical School, where she conducted research in the areas of childhood obesity and tobacco issues. She received her bachelor’s degree from Randolph-Macon College, her master’s degree from the University of Tennessee, and her doctorate from Virginia Commonwealth University.

Board Members

Anne B. Cropp, PharmD

Anne Cropp, PharmD, is Chief Scientific Officer of Early Access Care LLC, a health care company focused on facilitating all stakeholders involved in the review and approval of Expanded Access and Compassionate Use requests for investigational drugs.

Prior to founding Early Access Care, Cropp was Vice President in the Global Product Development Group at Pfizer Inc. She has 25 years of experience in the biopharmaceutical industry, marked by achievements in innovation and successful development of new drug products. As an innovator, Cropp has held a number of global leadership positions in R&D and has led matrixed development teams from Phase 1 through NDA/MAA submission and successful registration and commercialization. Her expertise in drug development spans Phases 1-4, both large and small molecules. She has expertise in planning and executing drug development programs for compounds with multiple routes of administration, including oral, intravenous, subcutaneous and inhalation, as well as devices for inhalation and injection.

Cropp has been responsible for the strategic planning, development and execution of investigational drugs across a wide spectrum of disease areas in adult and pediatric patients. She has developed and executed very large and mid-sized programs in disease areas that span Alzheimer’s disease, heart failure, hypercholesterolemia, hypertension, type I and II diabetes mellitus and vascular surgery.

Cropp served as Chair of the Pfizer Pediatric Council for eight years, and she advised pan-therapeutic area teams on issues related to planning for regulatory meetings, pediatric protocols, and execution of pediatric clinical trials.

Nieca Goldberg, MD

Nieca Goldberg, MD, is a cardiologist and a nationally recognized pioneer in women’s heart health. She serves as the Medical Director of the Joan H. Tisch Center for Women’s Health at NYU Langone Medical Center, the Clinical Associate Professor of Medicine at the NYU School of Medicine, and Co-Medical Director of the 92nd Street Y’s Cardiac Rehabilitation Center.

She is also a national spokesperson for the American Heart Association’s “Go Red” campaign and serves on the Woman’s Day Editorial Advisory Board. Since 2008, Goldberg has hosted “Beyond The Heart,” a weekly radio show on SiriusXM Doctor Radio.

Goldberg has received numerous awards for her advocacy work on women’s heart health, including the American Heart Association’s Dr. With Heart award, Woman’s Day magazine’s Red Dress Award, Jewish Women International’s Women to Watch” Award and the Women at Heart 2006 Honoree Award from the Links Greater New York Chapter.

Linda G. Griffith, PhD

Linda G. Griffith, PHD, is Professor of Teaching Innovation, Biological Engineering, and Mechanical Engineering, and Director of the Center for Gynepathology Research at the Massachusetts Institute of Technology (MIT).

Griffith received a bachelor’s degree from Georgia Tech and a PhD degree from the University of California at Berkeley, both in chemical engineering. She is a member of the National Academy of Engineering and the recipient of a MacArthur Foundation Fellowship.

Her research encompasses molecular-to-systems level analysis, design and synthesis of biomaterials, scaffolds, devices and micro-organs for a range of applications in regenerative medicine, tissue engineering, and in vitro drug development. A central theme is connecting the experimental systems to systems biology measurements. Most projects are highly interdisciplinary and translational, involving basic scientists, clinicians, and engineers, often with industry partners, to solve important problems in medicine and biology.

The Griffith lab also leads a substantial program to build the “Human Physiome on a Chip,” funded by DARPA and NIH. In this program, 10 microphysiological systems, including liver, gut, lung, and reproductive systems, are interconnected in a physiologically relevant manner. Griffith is also a member of SWHR’s Estrogen-Driven Diseases Network as both an endometriosis patient and a researcher whose work in endometriosis has been recognized by NIH’s Office of Research on Women’s Health as well as the Endometriosis Foundation of America.

Florence P. Haseltine, PhD, MD

Florence P. Haseltine, PhD, MD, is a board certified obstetrician and gynecologist and an expert in reproductive endocrinology. She is the founder of the Society for Women’s Health Research.

Haseltine received her undergraduate training at University of California at Berkeley, a doctorate in biophysics from the Massachusetts Institute of Technology, and an MD from the Albert Einstein College of Medicine. Following her internship at the University of Pennsylvania at Philadelphia and her residency at Boston Hospital for Women (Brigham and Women’s Hospital), she served as Assistant and Associate Professor in the Department of Ob/Gyn and Pediatrics at Yale University.

While at Yale University School of Medicine, she took a year of training at the School of Organization and Management in order to develop a proficiency in administration, policy, strategic planning and business development. She wrote computer programs for automating sperm counting and sold them to industry. She has served on the Scientific Advisory Board of Health Care Ventures, a venture capital group specializing in biotechnology.

The health of women and their advancement professionally are central issues for Haseltine. In 1990, she founded the Society for Women’s Health Research and was its first president. SWHR has brought the issue of research on women’s health to the attention of federal officials and prominent members of the media as well as placing it on the nation’s priority research agenda. As SWHR’s founder, Haseltine wrote mission statements, raised monies, established bylaws, and hired the original staff. She is also the founder of Haseltine Systems, a company devoted to easing travel for persons with disabilities.

Haseltine has co-edited and reviewed numerous publications and books on a range of topics, including reproductive biology, women’s health, and proceedings of NIH-sponsored conferences related to the reproductive sciences and population issues. She was also the founding editor of the Journal of Women’s Health. In addition, she has made many scientific, public, and media presentations across the country and internationally. She now concentrates on helping nonprofits in the medical advocacy area with their IT requirements. Her current activities include developing mobile apps for medicine. As an early adopter, her work as expanded to include such wearable devices as Google GLASS.

Haseltine was on the Board of Directors of the American Association for the Advancement of Science and the Society for Gynecologic Investigation. She is currently a board member of the American Women in Science and the Older Women’s League. She has been recognized for her contributions in the field of women’s health and reproductive science by election to the Institute of Medicine (IOM) and by receiving a variety of accolades. These awards include the following: the Weizmann Honored Scientist Award, the American Woman’s Medical Association Scientist Award, the Advocacy Award from Research!America for the Society for Women’s Health Research, and Kilby Laureate. She was also an honoree for Health Hero of the American Health for Women Magazine and for Prevention Magazine “Hall of Fame;” and Ladies’ Home Journal “Champions of Women’s Health.” She has received lifetime achievement awards from the United Nations Population Fund (UNFPA) and from the Foundation for the History of Women in Medicine (FHWIM).

David Page, MD

David Page, MD, is Director of the Whitehead Institute, a professor of biology at the Massachusetts Institute of Technology (MIT), and an investigator of the Howard Hughes Medical Institute.

His laboratory is exploring fundamental differences between males and females in health and disease, both within and beyond the reproductive tract. The Page lab recently discovered that XY and XX sex chromosomes account for subtle differences in the molecular biology of male and female cells and tissues throughout the body. This important finding emerged from the lab’s comparative genomic and evolutionary studies of the sex chromosomes of humans, other mammals, and birds.

Page serves on the Selection Committees of the March of Dimes Prize in Developmental Biology, the National Academy of Sciences Award in Molecular Biology, and the Taubman Prize in Translational Medical Science. He is a member of the advisory boards of Harvard Medical School and Harvard School of Dental Medicine, the Searle Scholar Program, and the Board of Directors of PepsiCo. He is a member of the National Academy of Sciences and the Institute of Medicine.

Page has received numerous awards including a MacArthur Prize Fellowship, the Amory Prize for Advances in Reproductive Biology and Medicine from the American Academy of Arts and Sciences, the Curt Stern Award from the American Society of Human Genetics, and the March of Dimes Prize in Developmental Biology.

Alan Wright, MD, MPH

Alan Wright, MD, MPH, is the chief medical officer at Roche Diagnostics Corp.

In this role he serves as Roche’s clinical spokesperson and provides guidance on a wide range of policy and clinical practice issues related to diagnostic medicine. Wright has extensive experience in the managed care, pharmaceutical and biotechnology industries.

Prior to joining Roche, Wright served as senior vice president of health improvement strategies for Miraca Life Sciences. He also worked as vice president for product strategy and business development for Resolution Health, a privately held analytics and intervention company serving the managed care market place.

Until 2005, Wright was chairman and CEO of Star Pharmaceuticals, a company that he founded in 2002 to serve the needs of the urological community. Previously, he held positions as senior vice president and chief science officer of Caremark and senior vice president and chief medical officer for AdvancePCS.

Wright graduated magna cum laude with a bachelor’s degree from Pennsylvania State University, received his medical doctorate from the University of Pennsylvania, and completed his residency in internal medicine at Temple University in Philadelphia. While at Temple, he served as chief medical resident from 1985 to 1986 and completed his MPH at Johns Hopkins.

Wright is a member of the American Medical Association, the American College of Physicians, and several journal editorial boards. He is also certified as a diplomat to the American Board of Internal Medicine and the National Board of Medical Examiners.

Michael Ybarra, MD

Michael Ybarra, MD, FAAEM, FACEP, is a board-certified emergency physician and vice president of medical affairs and strategic alliances at the Pharmaceutical Research and Manufacturers of America (PhRMA).

Ybarra is a graduate of Stanford University and Georgetown University School of Medicine, and he completed his residency training at MedStar Washington Hospital Center.

After residency, Ybarra practiced academic emergency medicine. He was the site director for emergency medicine residents at MedStar Georgetown University Hospital. He also became the founding program director of the Health Policy Fellowship, a partnership with MedStar Georgetown University Hospital, the McCourt School of Public Policy, and the Association of American Medical Colleges. He has authored a number of medical peer-reviewed publications, case reports, and book chapters.

Ybarra has served in various roles with the American Academy of Emergency Medicine, including as president of the Resident and Student Association and director of the Young Physicians Section. He is on the board of the Academy of Physicians in Clinical Research.

In 2014, Ybarra joined the PhRMA Advocacy and Strategic Alliances team. He oversees a team responsible for outreach to patient, provider, hospital, multicultural, and LGBT organizations on federal advocacy issues, including Medicare, Medicaid, FDA, and the 340B drug discount program. He continues to practice clinically in the Emergency Department at MedStar Georgetown University Hospital.